| Metric | Q3 2017 | Q2 2017 | Q3 2016 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $518M | $518M | $497M | -0.1% | 4.3% |
| Op. Income | $139M | $139M | $139M | 0.4% | 0.2% |
| Gross Margin | 82.7% | 83.0% | 83.0% | -0.4pp | -0.3pp |
| Net Margin | 18.9% | 18.0% | 18.5% | 0.9pp | 0.4pp |
| EPS (Diluted) | $1.52 | $1.43 | $1.37 | 6.3% | 10.9% |
| Free Cash Flow | $155M | $166M | $154M | -6.4% | 0.5% |
| Item | Amount |
|---|---|
| REVENUE | $518M |
| Cost of Revenue | $90M |
| GROSS PROFIT | $428M |
| R&D Expenses | $89M |
| Selling & Marketing | $161M |
| General & Administrative | $39M |
| SG&A Expenses | $200M |
| Other Expenses | $1.0K |
| Operating Expenses | $289M |
| Cost & Expenses | $379M |
| OPERATING INCOME | $139M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $142M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $98M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $98M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $98M |
| D&A | $15M |
| EBIT | $139M |
| EBITDA | $154M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $518M |
| Cost of Revenue | $90M |
| GROSS PROFIT | $428M |
| R&D Expenses | $89M |
| Selling & Marketing | $161M |
| General & Administrative | $39M |
| SG&A Expenses | $200M |
| Other Expenses | $1.0K |
| Operating Expenses | $289M |
| Cost & Expenses | $379M |
| OPERATING INCOME | $139M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $3M |
| INCOME BEFORE TAX | $142M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $98M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $98M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $98M |
| D&A | $15M |
| EBIT | $139M |
| EBITDA | $154M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $98M |
| Depreciation & Amortization | $15M |
| Stock-Based Compensation | $43M |
| Deferred Income Tax | -$1M |
| Other Non-Cash Items | -$526.0K |
| Change in Working Capital | $8M |
| OPERATING CASH FLOW | $163M |
| Capital Expenditure | -$7M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$109M |
| Sales/Maturities of Investments | $109M |
| Other Investing Activities | $36.0K |
| NET CASH FROM INVESTING | -$7M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$150M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $29M |
| NET CASH FROM FINANCING | -$121M |
| FREE CASH FLOW | $155M |
| Net Change in Cash | $35M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $691M |
| Short-Term Investments | $323M |
| Net Receivables | $295M |
| Inventory | $31M |
| Other Current Assets | $106M |
| TOTAL CURRENT ASSETS | $1.4B |
| PP&E (Net) | $125M |
| Goodwill | $556M |
| Intangible Assets | $0 |
| Long-Term Investments | $235M |
| Tax Assets | $2M |
| Other Non-Current Assets | $55M |
| TOTAL NON-CURRENT ASSETS | $973M |
| TOTAL ASSETS | $2.4B |
| Account Payables | $45M |
| Short-Term Debt | $0 |
| Deferred Revenue | $686M |
| Other Current Liabilities | $179M |
| TOTAL CURRENT LIABILITIES | $909M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $258M |
| Deferred Tax Liabilities | $6M |
| Other Non-Current Liabilities | $41M |
| TOTAL NON-CURRENT LIABILITIES | $305M |
| TOTAL LIABILITIES | $1.2B |
| Common Stock | $18M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $1.2B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$15M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.2B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.2B |
| TOTAL LIABILITIES & EQUITY | $2.4B |
| Total Debt | $0 |
| Net Debt | -$691M |
